Literature DB >> 11526480

Polyoma virus disrupts ARF signaling to p53.

M Lomax1, M Fried.   

Abstract

Polyoma virus (Py) differs from other small DNA tumor viruses in not encoding a protein that inactivates p53. The complete Py early region encoding the large T-antigen (PyLT), middle T-antigen (PyMT) and small T-antigen (PyST) will transform primary rodent cells and REF52 cells, but PyMT, the main Py oncogene, by itself will only transform these cells when p53 or ARF is inactivated. We have related Py oncogene cooperation with the effects of the Py T-antigens on the ARF-p53 signaling pathway. PyMT activates an ARF-induced p53-mediated block to cell division explaining the inability of PyMT alone to generate dividing transformed cells. In contrast, in REF52 cells transformed by the whole Py early region (PyREF52), ARF is upregulated but p53 is not activated. Thus PyLT and/or PyST negates the PyMT-induced ARF-mediated block to cell division by disrupting the signaling pathway from ARF to p53. Although there is no detectable interaction or co-localization of endogenous ARF (nucleoli) and MDM2 (nucleoplasm) in PyREF52 cells, expression of transfected ectopic ARF results in an MDM2/ARF interaction and sequestration of MDM2 into the nucleoli. Sequestration of MDM2 by ARF in the nucleoli is not essential for a p53 response in REF52 cells as activation of Raf in REF52Raf-ER cells results in an ARF-induced p53-mediated cell cycle block in the absence of a detectable ARF-MDM2 interaction. Py may provide new insights into the cellular ARF-p53 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526480     DOI: 10.1038/sj.onc.1204717

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control.

Authors:  Pablo Rodriguez-Viciana; Crista Collins; Mike Fried
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

2.  TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis.

Authors:  Anny Shai; David Dankort; Joseph Juan; Shon Green; Martin McMahon
Journal:  Cancer Res       Date:  2015-05-22       Impact factor: 12.701

3.  Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.

Authors:  Bobby Guillory; Amos M Sakwe; Margret Saria; Pamela Thompson; Christine Adhiambo; Rainelli Koumangoye; Billy Ballard; Awadh Binhazim; Cecil Cone; Willi Jahanen-Dechent; Josiah Ochieng
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

4.  Design stars: how small DNA viruses remodel the host nucleus.

Authors:  Mengxi Jiang; Michael J Imperiale
Journal:  Future Virol       Date:  2012-05-01       Impact factor: 1.831

5.  Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.

Authors:  Jonathan P Castillo; Fiona M Frame; Harry A Rogoff; Mary T Pickering; Andrew D Yurochko; Timothy F Kowalik
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Role for PP2A in ARF signaling to p53.

Authors:  Madeleine G Moule; Crista H Collins; Frank McCormick; Mike Fried
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

Review 7.  Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation.

Authors:  Kamel Khalili; Ilker Kudret Sariyer; Mahmut Safak
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

8.  The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation.

Authors:  Tamara Utermark; Brian S Schaffhausen; Thomas M Roberts; Jean J Zhao
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

9.  Induction and bypass of p53 during productive infection by polyomavirus.

Authors:  Dilip Dey; Jean Dahl; Sayeon Cho; Thomas L Benjamin
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers.

Authors:  Olena Odnokoz; Pengfei Yu; Amy R Peck; Yunguang Sun; Albert J Kovatich; Jeffrey A Hooke; Hai Hu; Edith P Mitchell; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Biol Ther       Date:  2020-05-07       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.